Systematic investment plans (SIP) stayed stable even as total flows to growth-oriented funds shrank 14%, to ₹35,943 crore, from October's ₹41,887 crore.
Site référencé: The Economic Times
The Economic Times
Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises 10%
31/07/2025
25% US tariff not a structural threat to Indian market : Vikas Khemani
31/07/2025
TVS Motor Q1 Results : Cons PAT jumps 32% YoY to Rs 610 crore, revenue rises 18%
31/07/2025
Which sectors will need a relook in terms of earnings projection now ? Gautam Duggad explains
31/07/2025
China summons Nvidia over alleged security risk in H20 AI chips
31/07/2025
Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on India
31/07/2025
